A case report of COVID‐19 in an asymptomatic patient with newly diagnosed breast cancer
Abstract COVID‐19 can be especially dangerous in vulnerable populations such as those with cancer undergoing treatment. When it is discovered in an asymptomatic patient through imaging, there is a paucity of evidence‐based treatment recommendations.
Main Authors: | Cindy Cen, Maria C. Shiau, Sylvia Adams, Freya Schnabel, Amber Guth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.3532 |
Similar Items
-
Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
by: Chieko Miyazaki, et al.
Published: (2019-09-01) -
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
by: V F Semiglazov, et al.
Published: (2013-12-01) -
Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01) -
Recommendations for breast surgical care during COVID-19 outbreak in Iran: setting priorities of management
by: R. Omranipour, et al.
Published: (2020-05-01) -
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
by: Hyder T, et al.
Published: (2021-03-01)